MOHAMMED M. DAR,JOYSON J. KARAKUNNEL,HAIYI JIANG,MAXWELL J. KIRKBY
申请号:
US16788488
公开号:
US20200171149A1
申请日:
2020.02.12
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and a tyrosine kinase inhibitor in a subject identified as having an EGFR mutation-positive tumor.